CLINICAL_TRIALS
trial_result
· 2026-03-09
Clinical Trial Update: Pregnancy, Anti-integrase and Lymphocyte Repertoire of the Newborn
Summary
This completed study from Paris hospitals examined how exposure to anti-integrase therapies during pregnancy affects the newborn's lymphocyte repertoire.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Anti-integrases | Status: COMPLETED